Pancreatic Cancer Research

ResearcherEugene Applebaum College of Pharmacy and Health SciencesActive in the last 2 years

Fei Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1679-9932; OpenAlex author ID A5100405374. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2017: 2 papers · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 10

  1. Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: insights from single-cell multi-omics. Co-author DOI 10.1186/s10020-024-00996-4↗
  2. LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. Co-author DOI 10.3389/fonc.2022.1004212↗
  3. The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer. Co-author DOI 10.1080/21655979.2021.1934243↗
  4. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas. Co-author DOI 10.3892/mmr.2020.11504↗
  5. Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. Co-author DOI 10.1158/1055-9965.epi-18-1235↗
  6. A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene. First author DOI 10.1371/journal.pgen.1008344↗
  7. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  8. Detection of K-ras gene mutations in feces by magnetic nanoprobe in patients with pancreatic cancer: A preliminary study. Co-author DOI 10.3892/etm.2017.5368↗
  9. Pathological and prognostic role of mdig in pancreatic cancer. Last author DOI 10.18632/genesandcancer.149↗
  10. Inherited pancreatic cancer. Co-author DOI 10.21037/cco.2017.12.04↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhengwei Song · 3 shared papers, 2020–2024 · strength 0.55
  2. Xiaoguang Wang · 4 shared papers, 2018–2022 · strength 0.52
  3. Bin Yan Wu · 2 shared papers, 2021–2024 · strength 0.42
  4. Zhengxiang Zhong · 3 shared papers, 2018–2021 · strength 0.36
  5. Lingyu Hu · 1 shared paper, 2024 · strength 0.28
  6. Haokai Xu · 2 shared papers, 2020–2021 · strength 0.25
  7. Wei Chen · 2 shared papers, 2020–2021 · strength 0.25
  8. Alison P. Klein · 3 shared papers, 2017–2019 · strength 0.25
  9. Nicholas Jason Roberts · 2 shared papers, 2017–2019 · strength 0.18
  10. Xiaorong Liu · 1 shared paper, 2022 · strength 0.16
  11. Peter Wang · 1 shared paper, 2022 · strength 0.16
  12. Lingyu Hu · 1 shared paper, 2021 · strength 0.14
  13. Sara H. Olson · 2 shared papers, 2019 · strength 0.14
  14. Steve Gallinger · 2 shared papers, 2019 · strength 0.14
  15. Gloria M. Petersen · 2 shared papers, 2019 · strength 0.14
  16. Lifeng Qi · 1 shared paper, 2018 · strength 0.11
  17. Srinivas Kumar · 1 shared paper, 2017 · strength 0.09
  18. Hongjuan Cui · 1 shared paper, 2017 · strength 0.09
  19. Spring Holter · 1 shared paper, 2019 · strength 0.07
  20. Cavin Wong · 1 shared paper, 2019 · strength 0.07
  21. Ayelet Borgida · 1 shared paper, 2019 · strength 0.07
  22. Yifan Wang · 1 shared paper, 2019 · strength 0.07
  23. Randall E. Brand · 1 shared paper, 2019 · strength 0.07
  24. Sapna Syngal · 1 shared paper, 2019 · strength 0.07
  25. Elena M. Stoffel · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.